CTN's clinical coordinating center contract. CTN study, optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (CTN-0100). POP: 8/15/24 - 4/2/28
Active Awarded Last action
- Contract number
- 75N95024F00003
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,944,274
Award facts
- Opportunity
-
- Clinical Coordinating Center for NIDA’s Clinical Trials Network Pre-Solicitation · 75N95024R00025 · Posted Aug 17, 2023
- Contract value 100% obligated
- $3,944,274.00 Current and potential, with all options
- Completion date 60% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $525,000 | |
| Original award | $3,419,274 |
About this award
The National Institute on Drug Abuse issued a delivery order to The Emmes Company, LLC on August 15, 2024, with a ceiling value of $3.9 million for clinical coordinating center services under the CTN Study, Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (CTN-0100).
Place of performance is Rockville, Maryland. The period of performance runs from August 15, 2024, through April 2, 2028. The order is priced on a cost-plus-fixed-fee basis and funds the clinical coordinating center for NIDA's Clinical Trials Network, supporting complex biomedical research coordination, data management, and clinical trial oversight.
In fiscal year 2024, the order invoiced $112 thousand across 0.4 FTEs and 762 contractor hours at a derived government-paid rate of $146.67 per hour. The Emmes Company self-performed all reported labor with no subcontractors engaged.
Quick answers
Who was awarded contract 75N95024F00003?
75N95024F00003 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on August 15, 2024.
How much is contract 75N95024F00003 worth?
The government has obligated $3,944,274 on 75N95024F00003.
Is contract 75N95024F00003 an order under another contract?
Yes. 75N95024F00003 is a delivery order under 75N95024D00037, an indefinite delivery contract.
Was contract 75N95024F00003 competed?
The extent of competition for 75N95024F00003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award